SCHEMBL28490356

SCHEMBL28490356

NCCCCC(C(=O)O)N1C(=O)CCC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
PKM P14618 1/20 0.49
GSR P00390 1/20 0.44
RNPEP Q9H4A4 1/20 0.43
CPB2 Q96IY4 7/20 0.40
FOLH1 Q04609 2/20 0.35
DPP9 Q86TI2 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
CPB1 P15086 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP7 Q9UHL4 1/20 0.35
KDM4E B2RXH2 1/20 0.34
TP53 P04637 1/20 0.34
GLA P06280 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
HPGD P15428 1/20 0.34
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1696971 1.00 ALDH1A1 (0.49) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1437767 0.95 ALDH1A1 (0.50) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1696964 0.93 ALDH1A1 (0.46) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL195776 0.93 ALDH1A1 (0.43) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL6794551 0.92 ALDH1A1 (0.42) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1696991 0.90 ALDH1A1 (0.41) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1696968 0.90 GSR (0.44) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1696978 0.89 ALDH1A1 (0.40) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL30773222 0.83 ALDH1A1 (0.49) ALDH1A1PKMFOLH1CYP1A2CYP2C19
SCHEMBL8530125 0.82 ALDH1A1 (0.51) ALDH1A1PKMFOLH1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112055749-A Use of FUBP1 inhibitors for the treatment of hepatitis B virus infection 豪夫迈·罗氏有限公司 2020-12-08 CN disclosed